Genetic Versus Epigenetic BRCA1 Silencing Pathways: Clinical Effects in Primary Ovarian Cancer Patients | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Ovarian Cancer

Genetic Versus Epigenetic BRCA1 Silencing Pathways: Clinical Effects in Primary Ovarian Cancer Patients

Online download statistics by month:

Online download statistics by month: January 2019 to November 2021

	Abstract	Full	Pdf
Jan 2019	14	0	3
Feb 2019	36	0	0
Mar 2019	29	0	0
Apr 2019	41	0	0
May 2019	75	0	1
Jun 2019	29	0	1
Jul 2019	36	0	0
Aug 2019	38	0	1
Sep 2019	30	0	0
Oct 2019	31	0	0
Nov 2019	65	0	2
Dec 2019	39	0	1
Jan 2020	48	0	0
Feb 2020	45	0	6
Mar 2020	35	0	1
Apr 2020	21	0	0
May 2020	24	0	2
Jun 2020	44	0	1
Jul 2020	46	0	3
Aug 2020	10	0	0
Sep 2020	32	0	2
Oct 2020	16	0	1
Nov 2020	21	0	2
Dec 2020	31	0	0
Jan 2021	63	0	2
Feb 2021	34	0	1
Mar 2021	31	0	0
Apr 2021	28	0	3
May 2021	7	0	0
Jun 2021	1	0	1
Jul 2021	0	0	1
Aug 2021	0	0	4
Sep 2021	1	0	5
Oct 2021	19	0	1
Nov 2021	25	0	2
Total	1045	0	47